AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$MCK

McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal

McKesson Corp. and Clayton Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake. Option Care shares surged 20% overnight, halted before trading. The deal, at a 37% premium, is expected to close in 2027.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 12:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$MCK
Neutral
high confidence
Mentioned
$MCK · $OPCH
Relevance
9/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$MCKNeutralHigh
01

Why it matters

The deal adds a strategic asset for McKesson while providing Option Care shareholders a premium exit.

02

Market read

The announcement drives immediate price moves and signals continued consolidation in the healthcare services sector.

03

What to watch

Regulatory approval risk and integration challenges could delay value realization.

Relevance 9/10Novelty 9/10Timing: today

Background

The acquisition expands McKesson's footprint into the medical infusion market, a growing segment of specialty care.

Company-level read

Ticker impact

$MCKNeutralHigh confidence
Context

McKesson announced a $5.8B acquisition of Option Care Health, investing $1.4B for a 49% stake.

Expected impact

potential slight downside as investors price the $1.4B cash investment

Evidence & confidence

The deal size is material but the market typically reacts cautiously to large acquisitions that require significant capital.

$OPCHBullishHigh confidence
Context

Option Care Health shares were halted then surged >20% after the $5.8B acquisition announcement with a 37% premium.

Expected impact

upward pressure as the market prices in the 37% premium and deal completion

Evidence & confidence

The announced premium and immediate 20% jump indicate strong buyer enthusiasm; the deal is expected to close in H1 2027.

Market effects

Sector

Healthcare services consolidation may boost valuations of other infusion and specialty pharmacy providers.

Regional

U.S. healthcare M&A activity could see heightened investor interest.

Global

Large U.S. healthcare deals influence global pharma and biotech investment sentiment.

Counterpoint

What could challenge this read

Some investors may view the cash outlay as overpaying, risking dilution of McKesson's balance sheet.

Key entities

  • Company
    McKesson Corp.

    U.S. healthcare services and distribution giant.

  • Company
    Option Care Health Inc.

    Provider of home and alternate site infusion services.

  • Private Equity
    Clayton Dubilier & Rice

    PE firm taking majority ownership of Option Care.

Read at source← All news

StoryMcKesson and CD&R agree $5.8 bn acquisition of Option Care Health

Also covered by

5 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min